Amlodipine Besylate Tablet
Product Images NDC 71610-620

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10 mg (71610 0620 30)

Amlodipine Besylate USP 10 mg oral tablets packaging label displaying 30 tablets per container. The label includes NDC number 71610-0620-30, storage instructions to keep at controlled room temperature, manufacturer Aphena Pharma Solutions - Tennessee, LLC, and dispensing instructions to use a tight light-resistant container. The label also lists manufacturer lot and expiration date details, with a barcode and verbiage to keep out of reach of children.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Effects-on-primary-endpoint-of-amlodipine (Effects On Primary Endpoint Of Amlodipine)

A forest plot chart depicting hazard ratios with 95% confidence intervals for various patient subgroups comparing Amlodipine versus placebo. Subgroups include overall patients, age groups (<85 and ≥85), gender (male and female), baseline sitting systolic blood pressure, baseline vessel disease status, presence of vessels with stenosis, and PCI-stent status. The x-axis shows hazard ratios from 0 to 2, indicating favor towards Amlodipine or placebo.*

FDA Label Image

Kaplan-meier-analysis (Kaplan Meier Analysis)

A line graph comparing event rates over 24 months between two groups labeled Amlodipine and Placebo. The vertical axis shows event rate, while the horizontal axis shows time in months. The graph includes statistical data with a p-value of 0.003 and a hazard ratio of 0.691 (95% CI 0.54 to 0.88). The number of subjects at risk is shown below the X axis at various time points.*

FDA Label Image

Structural-formula-of-amlodipine-besylate (Structural Formula)

Chemical structure diagram of amlodipine besylate, illustrating the molecular arrangement of atoms including chlorine, oxygen, nitrogen, methyl groups, and the besylate moiety attached to the amlodipine core.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.